Clinical Trial Update: Qishenyiqi Dripping Pill for Coronary Microvascular Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Qishenyiqi Dripping Pill evaluating its use in Coronary Microvascular Disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Disease

Drugs mentioned

• Qishenyiqi Dripping Pill

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Coronary Microvascular Disease | Phase 4 | Status: RECRUITING